Mutant U1-mediated aberrant alternative splicing inactivates tumor-suppressor genes (Ptch1, Pax5) and activates oncogenes (Gli2 and Ccnd2) or affects genes linked to SHH pathway (Pax6) or to other tumors (Tox4). The gene discussed is PTCH1; the disease is neoplasm.